Opiant Pharmaceuticals
0
0
+€0.00+0% 00:00 Hari ini
Statistik
Tertinggi harian
-
Paras terendah hari ini
-
Tertinggi 52M
-
Paras terendah 52M
-
Volum
-
Vol. purata
-
Kap. pasaran
0
Nisbah P/E
-
Hasil dividen
-
Dividen
-
Pesaing
Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ia bukan cadangan pelaburan.
Perihal
Opiant Pharmaceuticals, Inc. engages in the development of pharmaceutical solutions for common addictions and related disorders. The company is headquartered in Santa Monica, California and currently employs 3 full-time employees. The firm develops pharmacological treatments for substance use, addictive and eating disorders. The firm has developed NARCAN (naloxone hydrochloride) Nasal Spray, a treatment to reverse opioid overdoses, which was conceived, licensed, developed and approved by the United States Food and Drug Administration (FDA). The firm's pipeline of product candidates includes a treatment for Binge Eating Disorder (BED), a treatment for Bulimia Nervosa (BN), a treatment for Cocaine Use Disorder (CocUD) and a heroin vaccine. The firm also is focused on other treatment opportunities.
Tunjukkan lagi
CEO
Pekerja
30
Negara
Amerika Syarikat
ISIN
US6837501039
Penyenaraian
0 Komen
Kongsi pendapat anda
Soalan Lazim
Apakah simbol saham Opiant Pharmaceuticals?▼
Bergantung pada bursa, simbol saham mungkin berbeza. Sebagai contoh, di bursa Boerse Stuttgart, saham Opiant Pharmaceuticals didagangkan di bawah simbol 8OP.STU.
Berapa ramai pekerja yang dimiliki oleh Opiant Pharmaceuticals?▼
Sehingga 2 November 2026, syarikat mempunyai 30 pekerja.
Opiant Pharmaceuticals terletak dalam sektor apa?▼
Opiant Pharmaceuticals beroperasi dalam sektor Pembuatan.
Bilakah Opiant Pharmaceuticals menyiapkan split saham?▼
Pecahan saham terakhir bagi Opiant Pharmaceuticals berlaku pada 20 Ogos 2009 dengan nisbah 19:1.